References
- Arduino L. J. Chemotherapy in urologic cancer. Surg Clin N Amer 1965; 45: 1351
- Danielli J. F. Brit Emp Cancer Campaign Annual Rept 1959; 575
- Danielli J. F. Biological Approaches to Cancer Chemotherapy, R.J.C. Harris. Academic Press, New York 1961; 2
- Fex H. J., Högberg K. B., Könyves I., Kneip P. H. O. J. Certain steroid N-bis-(haloethyl)-carbamates. 1967, U.S. Patent no. 3 299 104, 17.1.
- Flocks R. H., Shu-Feng-Cheng. Combination therapy for prostatic carcinoma. J Iowa Med Soc 1969; 58: 125
- Fox M. The effect of cyklophosphamide on some urinary tumours. Brit J Urol 1965; 37: 399
- Jönsson G., Diczfalusy E., Plantin L. O., Röhl L., Birke G. Estradurin in the treatment of prostatic carcinoma. Acta Endocr (København) 1963, suppl. 83.
- Jönsson G. Treatment of prostatic carcinoma with polyestradiolphosphate combined with ethinylestradiol. Scand J Urol Nephrol 1971; 5: 97
- Kofman S., Eisenstein R. Mitramycin in the treatment of disseminated cancer. Cancer Chemother Rep 1963; 32: 77
- Lindstedt E., Lindergårdh B., Nilsén R. Arteriovenous shunts for transfusions. Lancet 1967; II: 512
- Mackenzie A. R., Duruman N., Whitmore W. F., Jr. Mitramycin in metastatic urogenital cancer. J Urol 1967; 98: 116
- The Veteran's Administration Cooperative Urological Research Group. 1967. Carcinoma of the prostate: Treatment comparisons. J Urol, 98: 516
- Weyrauch H. M., Nesbet J. D. Use of triethylene thio-phosphoramide (Thio-Tepa) in the treatment of advanced carcinoma of prostate. J Urol 1959; 81: 185